Hester Biosciences Limited

Equities

524669

INE782E01017

Delayed Bombay S.E. Other stock markets 10:11:21 20/05/2026 am IST			5-day change	1st Jan Change
1,859.00 ^INR	+3.46%		+8.80%	+16.78%

15/05	Hester Biosciences Limited, Q4 2026 Earnings Call, May 15, 2026
15/05	Hester Biosciences' Consolidated Profit Soars in Fiscal Q4; Shares Jump 10%	MT

Transcript : Hester Biosciences Limited, Q4 2025 Earnings Call, May 09, 2025

Published on 05/09/2025 at 04:50 pm IST - Modified on 05/17/2025 at 01:21 am IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good day, and welcome to Hester Biosciences Q4 and FY '25 Earnings Conference Call hosted by ICICI Securities Limited. [Operator

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Hester Biosciences Limited

15/05	Hester Biosciences Limited, Q4 2026 Earnings Call, May 15, 2026
15/05	Hester Biosciences' Consolidated Profit Soars in Fiscal Q4; Shares Jump 10%	MT
15/05	Hester Biosciences March-quarter consol net profit 159.8 million rupees	RE
15/05	Hester Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
11/03	Hester Biosciences Gets Board Nod to Divest 43.8% Stake in Subsidiary; Shares Up 3%	MT
11/03	Hester Biosciences approves divestment of 43.81% equity in Texas Lifesciences	RE
11/03	Ticop Life Private Limited entered into an agreement to acquire an additional 43.81% stake in Texas Laboratories from Hester Biosciences Limited for INR 92 million.	CI
30/01	Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
30/01	Hester Biosciences Limited, Q3 2026 Earnings Call, Jan 30, 2026
30/01	Hester Biosciences re-appoints Rajiv Gandhi as CEO & MD	RE
24/01	Hester Biosciences Limited Receives the Manufacturing License from the Food & Drugs Control Administration	CI
20/11	Hester Biosciences says Ashish Desai appointed as chief financial officer	RE
20/11	Hester Biosciences Appoints CFO	MT
20/11	Hester Biosciences Limited Appoints Ashish Desai as Key Managerial Personnel, with Effect from 20 November 2025	CI
20/11	Hester Biosciences Limited Appoints Ashish Desai as Chief Financial Officer, with Effect from 20 November 2025	CI